Goldman Sachs joined existing backers including software company SAP as Savo lifted its total funding to $84m.

TPG Biotech has now invest almost $28m in the skin disorder specialist, which will use the cash to advance clinical trials for its lead product.

Numerous private investors from the City of London back Oxford spin-out's move into the ophthalmology market with $33.5m.

The company's series B round was funded by SIG China, and it has now secured $30m in funding.

Verizon joined Intel and Lockheed Martin in Newlans' series B round, which brings its overall equity funding to about $27m.

The company raises $26m in series B, and $5.1m in a contract with DARPA.

China-based internet platform Renren led a group of investors in the round, which will fund the geographic expansion of Fundrise's crowdfunding network.

Eli Lilly led the latest round raised by Crown, which will use the cash to expand its drug testing services, and possibly for acquisitions.

The insurance quote aggregator's latest round, raised at a $100m valuation, brings its overall funding to about $30m.